Table of Contents Author Guidelines Submit a Manuscript
Advances in Hematology
Volume 2016, Article ID 9032627, 7 pages
http://dx.doi.org/10.1155/2016/9032627
Research Article

Seroprevalence of Hepatitis C, Hepatitis B, Cytomegalovirus, and Human Immunodeficiency Viruses in Multitransfused Thalassemic Children in Upper Egypt

1Department of Pediatrics, Faculty of Medicine, Sohag University, Sohag 82524, Egypt
2Department of Pediatrics, Faculty of Medicine, Minia University, Minia 61111, Egypt
3Department of Clinical Pathology, Faculty of Medicine, Sohag University, Sohag 82524, Egypt

Received 20 November 2015; Accepted 26 January 2016

Academic Editor: Meral Beksac

Copyright © 2016 Ramadan A. Mahmoud et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. L. Thein, “Genetic modifiers of β-thalassemia,” Haematologica, vol. 90, no. 5, pp. 649–660, 2005. View at Google Scholar · View at Scopus
  2. S. H. Ansari, T. S. Shamsi, M. Ashraf et al., “Molecular epidemiology of β-thalassemia in Pakistan: far reaching implications,” International Journal of Molecular Epidemiology and Genetics, vol. 2, no. 4, pp. 403–408, 2011. View at Google Scholar · View at Scopus
  3. A. El-Beshlawy, N. Kaddah, A. Moustafa, G. Mouktar, and I. Youssry, “Screening for β-thalassaemia carriers in Egypt: significance of the osmotic fragility test,” Eastern Mediterranean Health Journal, vol. 13, no. 4, pp. 780–786, 2007. View at Google Scholar · View at Scopus
  4. S. L. Schrier, “Pathophysiology of thalassemia,” Current Opinion in Hematology, vol. 9, no. 2, pp. 123–126, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Skarmoutsou, I. Papassotiriou, J. Traeger-Synodinos et al., “Erythroid bone marrow activity and red cell hemoglobinization in iron-sufficient β-thalassemia heterozygotes as reflected by soluble transferrin receptor and reticulocyte hemoglobin content. Correlation with genotypes and HB A2 levels,” Haematologica, vol. 88, no. 6, pp. 631–636, 2003. View at Google Scholar · View at Scopus
  6. S. Aziz, J. Rajper, and W. Noorulain, “Treatment outcome of HCV infected paediatric patients and young adults at Karachi, Pakistan,” Journal of Ayub Medical College, Abbottabad, vol. 24, no. 3-4, pp. 56–58, 2012. View at Google Scholar · View at Scopus
  7. F. Said, A. E. Beshlawy, M. Hamdy et al., “Intrafamilial transmission of hepatitis C infection in Egyptian multitransfused thalassemia patients,” Journal of Tropical Pediatrics, vol. 59, no. 4, pp. 309–313, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Hussein, “Evaluation of infectious disease markers in multi-transfused Egyptian children with thalassemia,” Annals of Clinical and Laboratory Science, vol. 44, no. 1, pp. 62–66, 2014. View at Google Scholar · View at Scopus
  9. A. A. Adly and F. S. Ebeid, “Cultural preferences and limited public resources influence the spectrum of thalassemia in Egypt,” Journal of Pediatric Hematology/Oncology, vol. 37, no. 4, pp. 281–284, 2015. View at Publisher · View at Google Scholar
  10. B. S. Buckner and E. B. Buckner, “Post-revolution Egypt: the Roy adaptation model in community,” Nursing Science Quarterly, vol. 28, no. 4, pp. 300–307, 2015. View at Publisher · View at Google Scholar
  11. C. Velati, L. Romanò, L. Fomiatti et al., “Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey,” Transfusion, vol. 48, no. 10, pp. 2205–2213, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. L. A. Quratul-Ain, M. Hassan, S. M. Rana, and F. Jabeen, “Prevalence of β-thalassemic patients associated with consanguinity and anti-HCV-antibody positivity—a cross sectional study,” Pakistan Journal of Zoology, vol. 43, no. 1, pp. 29–36, 2011. View at Google Scholar
  13. A. H. Mollah, N. Nahar, A. Siddique, K. S. Anwar, T. Hassan, and G. Azam, “Common transfusion-transmitted infectious agents among thalassaemic children in Bangladesh,” Journal of Health Population and Nutrition, vol. 21, no. 1, pp. 67–71, 2003. View at Google Scholar · View at Scopus
  14. J. M. Barrera, B. Francis, G. Ercilla et al., “Improved detection of anti-HCV in post-transfusion hepatitis by a third-generation ELISA,” Vox Sanguinis, vol. 68, no. 1, pp. 15–18, 1995. View at Publisher · View at Google Scholar · View at Scopus
  15. A. A. Adeyemi, O. A. Omolade, and R. R. Raheem-Ademola, “Immunochromatographic testing method for hepatitis B, C in blood donors,” Journal of Antivirals & Antiretrovirals, vol. 3, no. 10, pp. 4172–4175, 2013. View at Google Scholar
  16. H. Zaghloul and M. El-Shahat, “Recombinase polymerase amplification as a promising tool in hepatitis C virus diagnosis,” World Journal of Hepatology, vol. 6, no. 12, pp. 916–922, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Hussein, “Blood donor recruitment strategies and their impact on blood safety in Egypt,” Transfusion and Apheresis Science, vol. 50, no. 1, pp. 63–67, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. J. G. Donahue, A. Muñoz, P. M. Ness et al., “The declining risk of post-transfusion hepatitis C virus infection,” The New England Journal of Medicine, vol. 327, no. 6, pp. 369–373, 1992. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Al-Naamani, I. Al-Zakwani, S. Al-Sinani, F. Wasim, and S. Daar, “Prevalence of hepatitis C among multi-transfused thalassaemic patients in Oman, single centre experience,” Sultan Qaboos University Medical Journal, vol. 15, no. 1, pp. e46–e51, 2015. View at Google Scholar · View at Scopus
  20. S. L. Stramer, S. A. Glynn, S. H. Kleinman et al., “National heart, lung, and blood institute nucleic acid test study group. Detection of HIV-1 and HCV infections among antibody negative blood donors by nucleic acid-amplification testing,” The New England Journal of Medicine, vol. 351, no. 8, pp. 760–768, 2004. View at Publisher · View at Google Scholar
  21. M. Al-Sheyyab, A. Batieha, and M. El-Khateeb, “The prevalence of hepatitis B, hepatitis C and human immune deficiency virus markers in multi-transfused patients,” Journal of Tropical Pediatrics, vol. 47, no. 4, pp. 239–242, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Irshad and S. Peter, “Spectrum of viral hepatitis in thalassemic children receiving multiple blood transfusions,” Indian Journal of Gastroenterology, vol. 21, no. 5, pp. 183–184, 2002. View at Google Scholar · View at Scopus
  23. M. Rahman and Y. Lodhi, “Prospects and future of conservative management of beta thalassemia major in a developing country,” Pakistan Journal of Medical Sciences, vol. 20, no. 2, pp. 105–112, 2004. View at Google Scholar · View at Scopus
  24. E. Angelucci, P. Muretto, A. Nicolucci et al., “Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation,” Blood, vol. 100, no. 1, pp. 17–21, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. F. A. Ardalan, M. R. F. Osquei, M. N. Toosi, and G. Irvanloo, “Synergic effect of chronic hepatitis C infection and beta thalassemia major with marked hepatic iron overload on liver fibrosis: a retrospective cross-sectional study,” BMC Gastroenterology, vol. 4, article 17, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Zurlo, P. De Stefano, C. Borgna-Pignatti et al., “Survival and causes of death in thalassaemia major,” The Lancet, vol. 334, no. 8653, pp. 27–30, 1989. View at Publisher · View at Google Scholar · View at Scopus
  27. R. N. Makroo, J. S. Arora, M. Chowdhry, A. Bhatia, U. K. Thakur, and A. Minimol, “Red cell alloimmunization and infectious marker status (human immunodeficiency virus, hepatitis B virus and hepatitis C virus) in multiply transfused thalassemia patients of North India,” Indian Journal of Pathology and Microbiology, vol. 56, no. 4, pp. 378–383, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Mirmomen, S.-M. Alavian, B. Hajarizadeh et al., “Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infections in patients with beta-thalassemia in Iran: a multicenter study,” Archives of Iranian Medicine, vol. 9, no. 4, pp. 319–323, 2006. View at Google Scholar · View at Scopus
  29. W. Antar, M. H. El-Shokry, W. A. Abd El Hamid, and M. F. Helmy, “Significance of detecting anti-HBc among Egyptian male blood donors negative for HBsAg,” Transfusion Medicine, vol. 20, no. 6, pp. 409–413, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. Z. N. Said, M. H. El Sayed, I. I. Salama et al., “Occult hepatitis B virus infection among Egyptian blood donors,” World Journal of Hepatology, vol. 5, no. 2, pp. 64–73, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Altindis, I. Uslan, Z. Cetinkaya et al., “Investigation of hemodialysis patients in terms of the presence of occult hepatitis B,” Mikrobiyoloji Bülteni, vol. 41, no. 2, pp. 227–233, 2007. View at Google Scholar
  32. R. Jamal, G. Fadzillah, S. Z. Zulkifli, and M. Yasmin, “Seroprevalence of hepatitis B, hepatitis C, CMV and HIV in multiply transfused thalassemia patients: results from a thalassemia day care center in Malaysia,” Southeast Asian Journal of Tropical Medicine and Public Health, vol. 29, no. 4, pp. 792–804, 1998. View at Google Scholar · View at Scopus
  33. D. Oraby, “Harm reduction approach in Egypt: the insight of injecting drug users,” Harm Reduction Journal, vol. 10, article 17, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Manisha, K. Sanjeev, N. Seema, C. Dilip, and D. Rashmi, “A cross-sectional study on burden of hepatitis C, hepatitis B, HIV and syphilis in multi-transfused thalassemia major patients reporting to a Government Hospital of Central India,” Indian Journal of Hematology and Blood Transfusion, vol. 31, no. 3, pp. 367–373, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. J. E. Nelson and K. V. Kowdley, “Iron and hepatitis C,” Current Hepatitis Reports, vol. 3, no. 4, pp. 140–147, 2004. View at Publisher · View at Google Scholar
  36. S. Kakizaki, H. Takagi, N. Horiguchi et al., “Iron enhances hepatitis C virus replication in cultured human hepatocytes,” Liver, vol. 20, no. 2, pp. 125–128, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Hussain, R. Iqbal, M. H. Khan et al., “Prevalence of hepatitis C in β thalassaemia major,” Gomal Journal of Medical Sciences, vol. 6, no. 2, pp. 87–90, 2008. View at Google Scholar
  38. M. A. Shah, M. T. Khan, Z. Ullah, and Y. Ashfaq, “Prevalence of hepatitis B and C virus infection in multiple transfused thalassemic patients in North West Frontier Province,” Pakistan Journal of Medical Sciences, vol. 21, no. 4, pp. 281–283, 2005. View at Google Scholar
  39. M. R. Uddin, M. Rana, M. Islam et al., “Seroprevalence of hepatitis C virus in thalassemic patients,” Journal of Dhaka Medical College, vol. 18, no. 2, pp. 115–119, 2009. View at Google Scholar